文献速递糖尿病

尿液胆碱氧化代谢物预测2型糖尿病患者慢性肾脏病进展

Urine Choline Oxidation Metabolites Predict Chronic Kidney Disease Progression in Patients With Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在1894例2型糖尿病门诊患者中,中位随访9.2年期间263例发生慢性肾脏病进展;尿液胆碱和二甲甘氨酸每升高1个标准差,进展风险分别增加32%和30%,且与全因死亡风险独立相关。

要点

  • 尿液胆碱和二甲甘氨酸每升高1个标准差,CKD进展风险分别增加32%和30%
  • 尿液胆碱和二甲甘氨酸与肾小管病生物标志物dkk3正相关
  • 胆碱和二甲甘氨酸亦独立与全因死亡风险相关

核心结论

  • 尿液胆碱和二甲甘氨酸可独立预测2型糖尿病患者慢性肾脏病进展风险。

研究设计与样本

  • 从一家二级医院和一家初级保健机构招募1894例2型糖尿病门诊患者,采用液相色谱-质谱法测定尿液胆碱、甜菜碱、二甲甘氨酸和肌氨酸。

主要发现

  • 中位随访9.2年期间263例发生慢性肾脏病进展。
  • 校正临床危险因素后,尿液胆碱每升高1个标准差,CKD进展风险增加(校正HR 1.32,95%CI 1.16-1.51);二甲甘氨酸每升高1个标准差,CKD进展风险增加(校正HR 1.30,95%CI 1.14-1.47)。
  • 尿液胆碱和二甲甘氨酸与肾小管病生物标志物正相关,尤其是dkk3(Spearman rho分别为0.55和0.53)。
  • 相互校正后,dkk3与CKD进展的关联减弱,但胆碱、二甲甘氨酸与CKD进展的关联仍显著。
  • 胆碱和二甲甘氨酸亦独立与全因死亡风险相关(校正HR 1.20,95%CI 1.06-1.37;校正HR 1.17,95%CI 1.04-1.33)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Choline is metabolized in kidney tubules but the relationship between choline metabolism and kidney disease has not been systematically characterized. OBJECTIVE: To study whether urine metabolites in the choline oxidation pathway may predict the risk of chronic kidney disease (CKD) progression in individuals with type 2 diabetes. METHODS: Outpatients (n = 1894) with type 2 diabetes were recruited from a secondary hospital and a primary care facility. Urine choline, betaine, dimethylglycine, and sarcosine were measured by liquid chromatography-mass spectrometry. CKD progression was defined as a composite of incident end-stage kidney disease (sustained eGFR <15 mL/min/1.73m2, maintenance dialysis, renal death) and doubling of serum creatinine. RESULTS: CKD progression occurred in 263 participants during a median follow-up of 9.2 years. High levels of urine choline and dimethylglycine were associated with an increased risk of CKD progression after adjustment for clinical risk factors (adjusted HR [95% CI], 1.32 [1.16-1.51] and 1.30 [1.14-1.47], respectively, per 1 SD). Urine choline and dimethylglycine were positively correlated with tubulopathy biomarkers, especially dickkopf-related protein 3 (dkk3, Spearman rho 0.55 and 0.53). The association between dkk3 and CKD progression was diminished but the association between choline, dimethylglycine, and CKD progression remained significant after mutual adjustments. Choline and dimethylglycine were also independently associated with risk of all-cause death (adjusted HR 1.20 [1.06-1.37] and 1.17 [1.04-1.33], respectively). CONCLUSION: Urine choline and dimethylglycine independently predict the risk of CKD progression in individuals with type 2 diabetes. Dysregulation of intrarenal choline metabolism may be involved in tubulopathy leading to progressive loss of kidney function.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Liu JJ, Liu S, Gurung RL, et al. Urine Choline Oxidation Metabolites Predict Chronic Kidney Disease Progression in Patients With Type 2 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 40359238. doi:10.1210/clinem/dgaf281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。